Skip to main content
Virology Journal logoLink to Virology Journal
. 2015 Mar 14;12:43. doi: 10.1186/s12985-015-0270-z

Insights into the evolutionary history of Japanese encephalitis virus (JEV) based on whole-genome sequences comprising the five genotypes

Xiaoyan Gao 1,2,#, Hong Liu 3,#, Minghua Li 1,2, Shihong Fu 1,2, Guodong Liang 1,2,
PMCID: PMC4369081  PMID: 25884184

Abstract

Background

Japanese encephalitis virus (JEV) is the etiological agent of Japanese encephalitis (JE), one of the most serious viral encephalitis worldwide. Five genotypes have been classified based on phylogenetic analysis of the viral envelope gene or the complete genome. Previous studies based on four genotypes have reported that in evolutionary terms, genotype 1 JEV is the most recent lineage. However, until now, no systematic phylogenetic analysis was reported based on whole genomic sequence of all five JEV genotypes.

Findings

In this study, phylogenetic analysis using Bayesian Markov chain Monte Carlo simulations was conducted on the whole genomic sequences of all five genotypes of JEV. The results showed that the most recent common ancestor (TMRCA) for JEV is estimated to have occurred 3255 years ago (95% highest posterior density [HPD], −978 to−6125 years). Chronologically, this ancestral lineage diverged to produce five recognized virus genotypes in the sequence 5, 4, 3, 2 and 1. Population dynamics analysis indicated that the genetic diversity of the virus peaked during the following two periods: 1930–1960 and 1980–1990, and the population diversity of JEV remained relatively high after 2000.

Conclusions

Genotype 5 is the earliest recognized JEV lineage, and the genetic diversity of JEV has remained high since 2000.

Keywords: Japanese encephalitis virus, Genotype, Genetic diversity

Findings

Japanese encephalitis virus (JEV) is the prototype member of the JEV serogroup within the genus Flavivirus, family Flaviviridae. JEV comprises five genotypes (G1-G5) [1-3]. In previous studies, the phylogenetic characteristics of JEV were analyzed and the most recent common ancestor (TMRCA) was estimated. The TMRCA of JEV was estimated to be 1690 years when calculations were based on the complete sequence of four genotypes (G1-G4) [4], whereas, analysis of JEV using a limited number of whole genomic sequences from five genotypes indicated that TMRCA of JEV appeared approximately 460 years [5]. More recently, however, G5 strain XZ0934 isolated in 2009, which had not been included in earlier analyses, was shown to be significantly different from the G5 Muar isolate [6]. Therefore, in order to improve our understanding of the evolutionary progress and population diversity of JEV, a comprehensive dataset was established for evolutionary analysis of JEV in this study. In the dataset, 100 whole genomic sequences of JEV representing all five genotypes of JEV, isolated from various hosts (humans, pigs and bats) and vectors (mosquitoes and midges) were collected and analyzed.

Two G5 JEV full-length genome sequences (Muar and XZ0934) were downloaded from GenBank (GB No. HM596272 and JF915894, respectively) and added to the database established in a previous report [4], forming a new database for analysis (Table 1). The new JEV sequence database was analyzed using Bayesian Markov chain Monte Carlo (MCMC) method. The General Time Reversible (GTR) model + Invariant (I) + Gamma (G) model was selected using MrModelTest [7]. The nucleotide substitution rates and divergence times of the most recent common ancestor (TMRCA) were estimated using the relaxed (uncorrelated lognormal) molecular clock model in the BEAST software package [8]. Demographic histories of JEV were inferred based on Bayesian skyline reconstruction. The analysis was run through 1,000,000,000 generations to ensure sufficient mixing. Finally, the maximum clade credibility (MCC) tree was built using TreeAnnotator with 10% burn-in (http://beast.bio.ed.ac.uk/).

Table 1.

Information of JEV isolates analyzed in this study

Strain Date Country Host a Genotype GenBank accession no.
47 1950’s China:Heilongjiang CSF 3 JF706269
14178 2001 India - 3 EF623987
57434 2005 India - 3 EF623988
04940-4 2002 India - 3 EF623989
B58 1989 China:Yunnan Bat 3 FJ185036
Beijing-1 1949 China Human brain 3 L48961
BL06-50 2006 China:Guangxi Culex tritaeniorhynchus 1 JF706270
BL06-54 2006 China:Guangxi Culex tritaeniorhynchus 1 JF706271
CBH 1954 China:Fujian CSF 3 JN381860
CH-13 1957 China:Sichuan CSF 3 JN381870
CH1392 1990 Taiwan Culex tritaeniorhynchus 3 AF254452
CTS 1955 China:Fujian CSF 3 GQ429184
CZX 1954 China:Fujian CSF 3 JN381865
DH107 1989 China:Yunnan Aedes lineatopennis 3 JN381873
DL04-29 2004 China:Yunnan Culex theileri 3 JF706272
DL04-45 2004 China:Yunnan Ar. Subalbatus & Mansonia uniform 3 JN381854
Fj02-29 2002 China:Fujian CSF 3 JF706273
Fj02-76 2002 China:Fujian Human blood 3 JN381867
FJ03-39 2003 China:Fujian Human blood 3 JN381859
FJ03-94 2003 China:Fujian Human blood 3 JN381858
FU 1995 Australia Human serum 2 AF217620
G35 1954 China:Fujian Mosquito pool 3 GQ429185
GB30 1997 China:Yunnan Murina aurata brain tissue 3 FJ185037
GP78 1978 India Human brain 3 AF075723
GS07-TS11 2007 China:Gansu Culex tritaeniorhynchus 1 JN381843
GSBY0801 2008 China:Gansu Culex tritaeniorhynchus 1 JF706274
GSBY0804 2008 China:Gansu Culex tritaeniorhynchus 1 JN381844
GSBY0810 2008 China:Gansu Culex tritaeniorhynchus 1 JN381840
GSBY0816 2008 China:Gansu Culex tritaeniorhynchus 1 JN381842
GSBY0827 2008 China:Gansu Culex tritaeniorhynchus 1 JN381845
GSBY0861 2008 China:Gansu Culex tritaeniorhynchus 1 JN381833
GSS 1960’s China:Beijing CSF 3 JF706275
GX0519 2005 China:Guanxi Culex tritaeniorhynchus 1 JN381835
GX0523/44 2005 China:Guanxi Culex tritaeniorhynchus 1 JN381832
GZ04-2 2004 China:Guizhou Armigeres 3 JN381857
GZ56 2006 China:GuiZhou CSF 1 HM366552
Ha-3 1960’s China:Heilongjiang CSF 3 JN381872
HB49 1990 China:Yunnan Rousettus leschenaulti blood 3 JF706284
HB97 1990 China:Yunnan Rousettus leschenaulti blood 3 JF706285
HLJ02-134 2002 China:Heilongjiang Genus culicoides 3 JF706276
HN04-11 2004 China:Henan Culex 1 JN381831
HN04-21 2004 China:Henan Culex 1 JN381841
HN06129 2006 China:Henan Armigeres 1 JF706277
HN0621 2006 China:Henan Culex 1 JN381830
HN0626 2006 China:Henan Culex 1 JN381837
HVI 1965 Taiwan Mosquito 3 AF098735
HYZ 1979 China:Yunnan Patient blood 3 JN381853
Ishikawa 1994 Japan Culex tritaeniorhynchus 1 AB051292
JaGAr 01 1959 Japan Cluex 3 AF069076
JaOArS982 1982 Japan Mosquito 3 M18370
JaOH0566/Japan/1966/human 1966 Japan Human 3 AY508813
JEV/sw/Mie/40/2004 2004 Japan Swine serum 1 AB241118
JEV/sw/Mie/41/2002 2002 Japan Swine serum 1 AB241119
JH04-18 2004 China:Yunnan Whitmorei & Anophelessinensis 3 JN381855
JKT6468 1981 Indonesia Mosquito 4 AY184212
K87P39 1987 South Korea Mosquito 3 AY585242
KV1899 1999 Korea Swine 1 AY316157
LFM 1955 China:Fujian Human blood 3 JN381863
Ling 1965 Taiwan Human brain 3 L78128
LN02-102 2002 China:liaoning Culex modestus 1 JF706278
LN0716 2007 China:Liaoning Culex tritaeniorhynchus 1 JN381849
LYZ 1957 China:Fujian CSF 3 JN381869
M28 1977 China:Yunnan Culex pseudovishnui 1 JF706279
Nakayama 1935 Japan Human brain 3 EF571853
P3 1949 China:Beijing Human brain 3 U47032
RP-2 ms 1985 Taiwan Mosquito 3 AF014160
RP-9 1985 Taiwan Mosquito 3 AF014161
SA14 1954 China Mosquito 3 U14163
SC04-12 2004 China:Sichuan Culex 1 JN381839
SC04-15 2004 China:Sichuan Culex tritaeniorhynchus 1 JN381838
SD0810 2008 China:Shandong Culex tritaeniorhynchus 1 JF706286
SH03-103 2003 China:Shanghai Culex tritaeniorhynchus 1 JN381847
SH03-105 2003 China:Shanghai Culex tritaeniorhynchus 1 JN381846
SH04-10 2004 China:Shanghai Culex tritaeniorhynchus 3 JN381856
SH04-5 2004 China:Shanghai Culex tritaeniorhynchus 3 JN381866
SH17M-07 2007 China - 1 EU429297
SH-3 1987 China:Shanghai CSF 3 JN381864
SH-53 2001 China:Shanghai Culex tritaeniorhynchus 1 JN381850
SH-80 2001 China:Shanghai Culex tritaeniorhynchus 1 JN381848
T1P1 1997 Taiwan Armigeres subalbatus 3 AF254453
TLA 1971 China:Liaoning CSF 3 JN381868
Vellore P20778 1958 India Human brain 3 AF080251
XJ69 2007 China Culex pipiens pallens 1 EU880214
XJP613 2007 China Culex tritaeniorhynchus 1 EU693899
XZ0938 2009 China:Xizang Culex tritaeniorhynchus 1 HQ652538
YLG 1955 China:Fujian CSF 3 JF706280
YN 1954 China:Yunnan CSF 3 JN381871
YN05124 2005 China:Yunnan Culex tritaeniorhynchus 1 JF706281
YN05155 2005 China:Yunnan Culex tritaeniorhynchus 1 JN381852
YN0623 2006 China:Yunnan Culex tritaeniorhynchus 1 JN381836
YN0911 2009 China:Yunnan Culex tritaeniorhynchus 1 JF706267
YN0967 2009 China:Yunnan Culex tritaeniorhynchus 1 JF706268
YN79-Bao83 1979 China:Yunnan Culex tritaeniorhynchus 1 JN381851
YN82-BN8219 1982 China:Yunnan Mosquito 1 JN381834
YN83-Meng83-54 1983 China:Yunnan Lasiohelea taiwana Shiraki 1 JF706282
YN98-A151 2003 China:Yunnan Mosquitoes 3 JN381861
ZMT 1955 China:Fujian CSF 3 JF706283
ZSZ 1955 China:Fujian CSF 3 JN381862
Muar 1952 Malaysia Human brain 5 HM596272
XZ0934 2009 China:Tibet Culex tritaeniorhynchus 5 JF915894

a- Information not available.

Based on Bayesian Markov chain Monte Carlo (MCMC) analysis, the maximum clade credibility (MCC) tree for the whole genomic sequences of JEV was established (Figure 1). Representatives of the five distinct lineages were included in the analysis. The posterior probability values for the nodes of each lineage were >0.95, indicating their robustness. JEV was estimated to have emerged 3255 years ago (95% HPD: −978 to −6125 years) and subsequently diverged at least five times to produce the 5 recognized genotypes. In chronological order, they diverged in the order G5, G4, G3, G2 and G1. Thus, G5 represents the most ancestral lineage among genotypes 1–5.

Figure 1.

Figure 1

Maximum clade credibility (MCC) tree for 100 whole-genome sequences of JEV. Five distinct lineages were identified: G1 (red), G2 (yellow), G3 (blue), G4 (green) and G5 (orange). Estimated TMRCAs of these lineages (with their 95% HPD values in parentheses) are shown, G1: 155(104–315), G2: 530(235–1131), G3: 880(420–1855), G4: 1653(765–3372), and G5: 3255(978–6125).

The mean rate of nucleotide substitution for the whole genomic sequences of 100 JEV strains isolated from a variety of hosts worldwide, estimated using a Bayesian MCMC approach, was 1.01 × 10−4 nucleotide substitutions per site per year (95% HPD values, 4.37 × 10−5, 1.56 × 10−4). This is similar to previous estimates based on analysis of four JEV genotypes [4].

The population dynamics of JEV are shown in Figure 2. The skyline plot showed that the JEV population had experienced complicated changes during the process of evolution. However, the virus population remained relatively stable during the first 2700 years (Figure 2A), followed by a period of rapid decline from the 1700s, reaching a minimum in the 1900s. It then increased rapidly from the 1930s until the 1960s and formed the first peak. The second peak appeared in the 1980-1990s and subsequently the populations of JEV remained high after 2000 (Figure 2B).

Figure 2.

Figure 2

Bayesian skyline plots for JEV. Highlighted areas correspond to 95% HPD intervals. (A) Populations during the whole evolutionary history; (B) Populations during the later evolutionary history since 1800.

The findings in this study have similarities with previous studies [5]. For example, the divergence pattern of the genotypes occurred in the order G5, G4, G3, G2 and G1, and the mean rate of nucleotide substitution was similar to previous estimates. However, the occurrence time of TMRCA determined in this study (~3255 years ago) was quite different compared with that measured in the report (~460 years ago) of Mohammed et al. [5]. The reason for this discrepancy could be attributed to the dataset used for analysis. In Mohammed’s study, only 35 whole genomic sequences were used and the only G5 representative included was the Muar strain. Therefore, since our new dataset includes two G5 representatives with robust sequences, the occurrence time of TMRCA (~3255 years ago) obtained in this study should reflect more precisely the evolutionary patterns and diversity of JEV.

Two main peak periods in population dynamics were identified in this study, 1930–1960 and 1980-1990s, respectively. These fluctuations were reflections of the virus activity in the sylvatic environment. Since the 1930s, JEV strains belonging to G3 emerged and were isolated from Asian countries. G5 was first identified in 1952 [2,4]. This was a good interpretation of the first peak. Subsequently, G2 and G4 strains were isolated during the 1980s. Importantly, the G1 genotype emerged during the 1980s onwards [4]. Therefore, the virus population diversity peaked in the 1980-1990s. Since 2000, G1 JEV has become the dominant genotype in most endemic regions [4], and although a relatively small decrease was observed, the virus remains the most active and G5 reemerged.

Interestingly, although G5 is estimated to be the most ancestral JEV lineage, this virus showed a highly active dispersal capacity following its reemergence. Indeed, this new G5 strain was isolated from mosquitoes collected in southern region of the Asian continent (Tibet, China) in 2009 [2] and northeast region of Asia (South Korea) during the same year [9]. Thus, G5 now appears to be dispersing widely in Asia. A recent study showed that genotype 1 JEV originated in Southeastern Asia and spread to the entire Asian continent [10]. Based on these observations, it seems likely that G5 will follow a dispersal pattern similar to that of G1 JEV, and has dispersed or will disperse over the entire Asian continent. Clearly, G5 should be monitored closely throughout JEV endemic regions.

Finally, the available inactivated and live attenuated JE vaccines are derived from G3 JEVs [11]. Thus, the level of cross protection of the current vaccines against G5 JEV is likely to be sub-optimal and should therefore be analyzed carefully since the reemergence of G5 and its widespread dispersal, and significant genetic variation could impact on its epidemiology. This possibility is emphasized by the fact that Muar (the first G5 JEV) strain was isolated from a patient with severe viral encephalitis [12]. Thus, there is the realistic possibility that the newly isolated G5 viruses could be highly virulent. Thus, the potential disease burden of viral encephalitis caused by G5 JEV requires careful reassessment.

Acknowledgements

We appreciate Dr. Ernest A Gould from Aix Marseille University for his important revisions and comments on the manuscript. This work was supported by grants from the National Natural Science Foundation of China (81290342), the Ministry of Science and Technology, China (2011CB504702), and State Key Laboratory for Infectious Disease Prevention and Control (2014SKLID03).

Abbreviations

JEV

Japanese encephalitis virus

JE

Japanese encephalitis

E

Envelope

TMRCA

The most recent common ancestor

HPD

Highest posterior density

G

Genotype

MCMC

Markov chain Monte Carlo

MCC

Maximum clade credibility

Ser

Serine

ORF

Open reading frame

Footnotes

Xiaoyan Gao and Hong Liu contributed equally to this work.

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

XYG and HL contributed equally to the analysis and interpretation of the results, and involved in drafting the manuscript. MHL and SHF participated in the design and analysis of the dataset. GDL contributed to conception and design of the manuscript, and involved in drafting and revising the manuscript. All authors have read and approved the final version of the manuscript.

Contributor Information

Xiaoyan Gao, Email: g.x.y1018@hotmail.com.

Hong Liu, Email: liuhongseminar@126.com.

Minghua Li, Email: minghua-li@hotmail.com.

Shihong Fu, Email: shihongfu@hotmail.com.

Guodong Liang, Email: gdliang@hotmail.com.

References

  • 1.Uchil PD, Satchidanandam V. Phylogenetic analysis of Japanese encephalitis virus: envelope gene based analysis reveals a fifth genotype, geographic clustering, and multiple introductions of the virus into the Indian subcontinent. Am J Trop Med Hyg. 2001;65(3):242–51. doi: 10.4269/ajtmh.2001.65.242. [DOI] [PubMed] [Google Scholar]
  • 2.Li MH, Fu SH, Chen WX, Wang HY, Guo YH, Liu QY, et al. Genotype V Japanese encephalitis virus is emerging. PLoS Negl Trop Dis. 2011;5(7):e1231. doi: 10.1371/journal.pntd.0001231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Solomon T, Ni H, Beasley DW, Ekkelenkamp M, Cardosa MJ, Barrett AD. Origin and evolution of Japanese encephalitis virus in southeast Asia. J Virol. 2003;77(5):3091–8. doi: 10.1128/JVI.77.5.3091-3098.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Pan XL, Liu H, Wang HY, Fu SH, Liu HZ, Zhang HL, et al. The Emergence of Genotype I of Japanese Encephalitis Virus as the Dominant Genotype in Asia. J Virol. 2011;85(19):9847–53. doi: 10.1128/JVI.00825-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Mohammed MA, Galbraith SE, Radford AD, Dove W, Takasaki T, Kurane I, et al. Molecular phylogenetic and evolutionary analyses of Muar strain of Japanese encephalitis virus reveal it is the missing fifth genotype. Infect Genet Evol. 2011;11(5):855–62. doi: 10.1016/j.meegid.2011.01.020. [DOI] [PubMed] [Google Scholar]
  • 6.Li MH, Fu SH, Chen WX, Wang HY, Cao YX, Liang GD. Molecular Characterization of Full-length Genome of Japanese Encephalitis Virus Genotype V Isolated from Tibet. China Biomed Environ Sci. 2014;27(4):231–9. doi: 10.3967/bes2014.046. [DOI] [PubMed] [Google Scholar]
  • 7.Posada D. Using MODELTEST and PAUP* to select a model of nucleotide substitution. Curr Protoc Bioinformatics. 2003. Chapter 6, Unit 6.5 http://www.ncbi.nlm.nih.gov/pubmed/18428705/. [DOI] [PubMed]
  • 8.Drummond AJ, Rambaut A. BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol Biol. 2007;7:214. doi: 10.1186/1471-2148-7-214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Takhampunya R, Kim HC, Tippayachai B, Kengluecha A, Klein TA, Lee WJ, et al. Emergence of Japanese encephalitis virus genotype V in the Republic of Korea. Virol J. 2011;8:449. doi: 10.1186/1743-422X-8-449. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Gao XY, Liu H, Wang HY, Fu SH, Guo ZY, Liang GD. Southernmost Asia is the source of Japanese encephalitis virus (Genotype 1) diversity from which the viruses disperse and evolve throughout Asia. PLoS Negl Trop Dis. 2013;7(9):e2459. doi: 10.1371/journal.pntd.0002459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Halstead SB, Jacobson J. Japanese encephalitis vaccines. In: Plotkin SA, Orenstein WA, Offit PA, editors. Vaccine. 5. Phildelphia: Elsevier; 2008. pp. 311–52. [Google Scholar]
  • 12.Hale JH, Lim KA, Chee PH. Japanese type B encephalitis in Malaya. Ann Trop Med Parasitol. 1952;46(3):220–6. doi: 10.1080/00034983.1952.11685526. [DOI] [PubMed] [Google Scholar]

Articles from Virology Journal are provided here courtesy of BMC

RESOURCES